Cabot Stock of the Week 338
My quest to add some growthy stocks with a cyclical dimension and downside protection brings us to our latest recommendation.
Read More
When you invest in a stock, you buy a small portion of a company. The value of your stock rises and falls in conjunction with the performance of that company. But when you buy stocks that pay dividends, you get a little bonus. When these stocks earns a profit, it shares some of that profit with stockholders.
What do you need to do to get in on that action? Nothing. As long as you own the stock, you are eligible for monthly, quarterly, or yearly dividend payments. While dividends aren’t guaranteed, most companies are reluctant to cut them as that sends a troubling signal to investors. That makes investing in dividend stocks a low-risk, steady way to bring regular income into your portfolio.
When a company pays a dividend—and especially if it makes an effort to increase that payment every year—it shows that it cares about rewarding shareholders. These payments are also a savvy way to attract investors, which is why their share prices typically appreciate over time.
What do these stocks look like? They tend to be household names like Target Corp. (TGT), CVS Health Corp. (CVS), and Best Buy Co. (BBY). But you’ll also find a number of lesser known companies that have paid consistent dividends for years.
To find these stocks, search for investments with timelessness and longevity—companies that are sure to not only be around 20 or 30 years from now, but still thriving. Dividend stocks become more powerful, and usually make up a larger part of your annual return, the longer you hold on to them.
To learn more and find out how to invest in the best dividend stocks, download our FREE report, Cabot’s 5 Best Dividend Stocks. It’s your guide to finding the investments that will fund your future.
My quest to add some growthy stocks with a cyclical dimension and downside protection brings us to our latest recommendation.
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Stock Recommendation Tracker
The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More
Today’s note includes earnings updates, ratings changes and the podcast.
Read More
Suffice to say the last two weeks have been very tough. On the one hand, yes, of course some sort of correction or pullback has been expected given the huge progress the market – and growth stocks, small caps and IPOs in particular have...
Read More
The sellers ran wild today, with the Dow losing 346 points, the Nasdaq falling 274 points (2.1%) and the average growth stock we own or watch down nearly 5%. From late January through late February, we began to see a change in character, a..
Read More
The market is hitting a little turbulence, which is natural as it feels its way across the timing of the pandemic economic recovery, concern over debt, interest rates, and inflation.
Read More
The Big Idea
One of the unsung heroes of the online retail boom is a largely unknown technology – digital printing on fabrics and textiles.
While many traditional manufacturers and retailers of clothes, fashion items and home décor were destroyed during the pandemic, the inverse true...
Read More
I’m tempted—I really am—to take some of our 46% cash position and move it back into marijuana stocks. Since the sector peaked three weeks ago, most of the stocks have had a decent pullback and now the best are moving up again, heading those...
Read More
The market has gotten a little choppy and interest rates are to blame. At least, that’s what they say. The market indexes fell last week and have been all over the place so far this week.
Read More
Arena Pharmaceuticals (ARNA) yesterday announced that olorinab failed to meet the primary endpoint in the Phase 2 CAPTIVATE study in IBS abdominal pain. This is disappointing but not remotely the reason to own (or sell) the stock. IBS is a difficult to treat condition when...
Read More
Vaccines are being rolled out, and the economic recovery will be strong in 2021. Stocks that will benefit from the economic recover should have strong tailwinds. While our entire portfolio should benefit from an improving economy, two stand out to me.
Read More
We’re watching market sentiment gyrate sharply between “the economic reopening will boost earnings” and “the economic reopening will boost inflation”. Both outcomes are likely.
Read More
After a rough week, the market is right back in business. Just when stocks appeared on the cusp of a deeper selloff, the S&P 500 started off this week with the best session since June.
Read More
Last night, Medexus Pharma (MEDXF) reported excellent results. Revenue increased 70% y/y to $31.5MM in the quarter. While that top-line number benefitted from ~$3MM of sales that slipped from last quarter to this quarter, it was nonetheless a very positive report. Adjusted EBITDA increased to from...
Read More
Fears of rising inflation, and what that would mean for interest rates, weighed on the market last week, especially growth stocks, which were crushed.
Read More
Cardlytics (CDLX) reported Q4 2020 numbers this morning that surpassed revenue expectations by roughly 10% and missed modestly on earnings. Revenue was down 3.2% to $67.1 million (beating by $6.2 million) while adjusted EPS of -$0.05 missed by $0.02. Management gave 2021 guidance that for...
Read More
While some segments of the broad market have experienced a sharp correction over the past month (growth stocks in particular), the broad market has not fallen apart; in fact, many indexes hit new highs just last week. And, of course, today’s big jump rather...
Read More
This list of the best investment sites to research stocks aims to help individual investors navigate the sea of stock-related information on the web.
Read More
With the clean energy revolution in full swing, these 2 low-risk alternative energy stocks are a way for conservative investors to play it.
Read More